Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry

Podobne knjige/članki

• Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
  od: Pappas, Dimitrios A., et al.
  Izdano: (2020)
• Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry
  od: Harrold, Leslie R., et al.
  Izdano: (2015)
• Greater Likelihood of Remission in Rheumatoid Arthritis Patients Treated Earlier in Disease Course: Results from the CORRONA Registry
  od: Furst, Daniel E., et al.
  Izdano: (2011)
• Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
  od: Harrold, Leslie R., et al.
  Izdano: (2016)
• Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry
  od: Pappas, Dimitrios A., et al.
  Izdano: (2016)